229 related articles for article (PubMed ID: 11134213)
21. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.
Rousseau P; Flamant F; Quintana E; Voute PA; Gentet JC
J Clin Oncol; 1994 Mar; 12(3):516-21. PubMed ID: 7509854
[TBL] [Abstract][Full Text] [Related]
22. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?
Schuck A; Mattke AC; Schmidt B; Kunz DS; Harms D; Knietig R; Treuner J; Koscielniak E
J Clin Oncol; 2004 Jan; 22(1):143-9. PubMed ID: 14701776
[TBL] [Abstract][Full Text] [Related]
23. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC
J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146
[TBL] [Abstract][Full Text] [Related]
24. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group.
Raney B; Huh W; Hawkins D; Hayes-Jordan A; Million L; Rodeberg D; Teot L; Anderson J;
Pediatr Blood Cancer; 2013 Mar; 60(3):371-6. PubMed ID: 22961750
[TBL] [Abstract][Full Text] [Related]
25. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
Chargari C; Haie-Meder C; Guérin F; Minard-Colin V; de Lambert G; Mazeron R; Escande A; Marsolat F; Dumas I; Deutsch E; Valteau-Couanet D; Audry G; Oberlin O; Martelli H
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):352-359. PubMed ID: 28463154
[TBL] [Abstract][Full Text] [Related]
26. Orbital rhabdomyosarcoma: multidisciplinary treatment experience.
Forstner D; Borg M; Saxon B
Australas Radiol; 2006 Feb; 50(1):41-5. PubMed ID: 16499726
[TBL] [Abstract][Full Text] [Related]
27. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
[TBL] [Abstract][Full Text] [Related]
28. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
[TBL] [Abstract][Full Text] [Related]
29. Treatment of nonmetastatic cranial parameningeal rhabdomyosarcoma in children younger than 3 years old: results from international society of pediatric oncology studies MMT 89 and 95.
Defachelles AS; Rey A; Oberlin O; Spooner D; Stevens MC
J Clin Oncol; 2009 Mar; 27(8):1310-5. PubMed ID: 19204197
[TBL] [Abstract][Full Text] [Related]
30. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
[TBL] [Abstract][Full Text] [Related]
31. Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma.
Casey DL; Wexler LH; LaQuaglia MP; Meyers PA; Wolden SL
Pediatr Blood Cancer; 2014 Sep; 61(9):1565-9. PubMed ID: 24798662
[TBL] [Abstract][Full Text] [Related]
32. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary.
Orbach D; Brisse H; Helfre S; Freneaux P; Husseini K; Aerts I; Desjardins L; Fattet S
Expert Opin Pharmacother; 2003 Dec; 4(12):2165-74. PubMed ID: 14640915
[TBL] [Abstract][Full Text] [Related]
34. Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
Orbach D; Mosseri V; Gallego S; Kelsey A; Devalck C; Brenann B; van Noesel MM; Bergeron C; Merks JH; Rechnitzer C; Jenney M; Minard-Colin V; Stevens M
Head Neck; 2017 Jan; 39(1):24-31. PubMed ID: 27459057
[TBL] [Abstract][Full Text] [Related]
35. [Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology].
Treuner J; Kaatsch P; Anger Y; Seipp A; Spaar HJ; Gerein V; Suder J; Niethammer D
Klin Padiatr; 1986; 198(3):208-17. PubMed ID: 3523026
[TBL] [Abstract][Full Text] [Related]
36. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
[TBL] [Abstract][Full Text] [Related]
37. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G
Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336
[TBL] [Abstract][Full Text] [Related]
38. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
[TBL] [Abstract][Full Text] [Related]
39. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
[TBL] [Abstract][Full Text] [Related]
40. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]